S

Smith+Nephew

Global medical devices for orthopedics

Electrical Automation Engineer 2

Full-TimeUpdated on 10/23/2026
No salary listed
Mid
Bachelor's
Fort Worth, TX, USA
In PersonTravel up to 10% internationally and domestically.
Electrical EngineeringControls & Automation Engineering
No H1B Sponsorship

About the job

Requirements
  • A bachelor's degree in engineering or a related field is required.
  • At least 3 years of experience in a pharmaceutical or biotechnology environment, or at least 1 year in an Automation Engineer role with consistent performance, is required.
  • Strong working knowledge and experience with programmable logic controllers (PLCs), human-machine interfaces (HMIs), and supervisory control and data acquisition (SCADA) systems are required.
  • Demonstrated project management experience for automation solutions with proven results is required.
  • The candidate must be able to interpret design documentation, equipment manuals, and piping and instrumentation diagrams in English.
  • The candidate must adhere to quality systems and good manufacturing practices.
  • The candidate must be able to work as a group leader, facilitator, or participant in a professional, multidisciplinary, multicultural team.
  • The candidate must be able to influence team members, peers, and senior managers.
  • Strong analytical and troubleshooting skills are required.
  • The candidate must be able to prioritize multiple projects and multitask.
  • Effective verbal and written communication skills are required.
  • The candidate must be able to identify opportunities to implement automated systems and optimize existing automation processes.
  • The candidate must be proficient with Microsoft Project or Excel, Word, and PowerPoint.
  • The candidate must be able to walk, stand, lift up to 40 pounds, climb ladders or stairs, enter confined spaces, and work in high-noise areas.
  • The role requires up to 10% domestic and international travel.
Responsibilities
  • Provide automation subject matter expertise for equipment or systems, troubleshoot operations, and implement changes to improve efficiency.
  • Participate in daily operations when needed to meet schedules or resolve complex problems.
  • Audit the operational performance and regulatory compliance of a moderate number of complex equipment items or systems.
  • Work with multiple departments to develop requirements and recommendations for system modifications.
  • Guide and mentor junior team members on automation best practices and methodologies.
  • Translate and execute validation requirements for new or modified manufacturing and utility equipment and systems, ensuring they are available for good manufacturing practice manufacturing, compliant, and reliably perform their validated functions.
  • Participate in factory acceptance testing, commissioning new equipment, installation qualification, operational qualification, performance qualification, validation summary reports, and Part 11 compliance as required for manufacturing, utilities, and computerized systems.
  • Develop and lead projects, ensuring technical alignment with commercial and marketing strategy, and manage the project and project team against milestones and targets.
  • Drive development and operational delivery of project plans according to project management best practices, company standard operating procedures and guidance documents, and product profiles.
  • Manage project risks, budgets, schedule variance, and change management, and report to executive management as appropriate.
  • Complete capital requests and purchase orders as needed to support projects.
  • Generate quality documentation, including standard operating procedures, change controls, user requirement specifications, room specifications, validation protocols, job plan instructions, non-conformances, and corrective and preventive actions.
  • Perform risk assessments and gap assessments for equipment, processes, methods, and facility technology transfers.
Desired Qualifications
  • An electrical engineering degree is preferred.
  • An Engineer-in-Training or Professional Engineer license is preferred.
  • Lean or Six Sigma certification is highly desired.
  • Project Management Professional certification is a plus.
  • Working knowledge of aseptic manufacturing and fermentation processes is a plus.

About the company

Smith+Nephew is a global medical technology company that designs and makes medical devices for orthopaedics, sports medicine, and advanced wound care. Its products help surgeons treat joints and soft tissues and support patient recovery, including knee repair systems, single-use negative pressure wound therapy devices, and other extremity orthopaedic products. These devices are used in hospitals and clinics to perform procedures and support healing, often after surgery or injury. The company differentiates itself with a broad, worldwide product portfolio and collaborations with healthcare organizations to improve care and efficiency for patients and providers. Its goal is to improve patient outcomes, streamline medical procedures, and expand access to advanced medical solutions around the world.

Company Size

10,001+

Company Stage

IPO

Headquarters

Watford, United Kingdom

Founded

1856

Get referred to Smith+Nephew

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue reached $1.5 billion, and full-year guidance stayed intact on May 6.
  • New launches in 2026 include CORI XT, FLOW FLEXTEND, and ALLEVYN COMPLETE CARE.
  • August 2026 H1 results showed 4.6% growth, $200 million efficiency savings, and $500 million buyback.

What critics are saying

  • Reuters on August 4, 2026 cut revenue guidance to around 4% after weak U.S. knees.
  • Smith+Nephew’s finance chief John Rogers exits September 30, 2026, creating leadership churn.
  • A March 2026 humeral nail recall and older hip litigation expose recurring quality risk.

What makes Smith+Nephew unique

  • Smith+Nephew’s CORI XT robotics spans knee, shoulder, and future hip workflows.
  • Its ASC Solutions bundles facility design, financing, and clinical enablement for outpatient surgery.
  • ALLEVYN, RENASYS, and LEAF create a broad wound-care platform with measurable outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Paid Holidays
  • Flexible Work Hours
  • Parental Leave
  • Fertility Treatment Support
  • Family Planning Benefits
  • Tuition Reimbursement

Company News

Yahoo Finance
Oct 23rd, 2026
Smith & Nephew's $22B talks to buy J&J's orthopaedics unit collapse over who would lead

Smith & Nephew's merger talks with Johnson & Johnson (J&J) over its orthopaedics unit collapsed over who would lead the combined company, the Financial Times reported. The sides had reportedly agreed on the main financial terms and the deal structure. J&J wanted Namal Nawana, who runs its orthopaedics unit and formerly led Smith & Nephew, to lead the business. Smith & Nephew wanted current chief executive officer Deepak Nath to stay. Smith & Nephew's offer valued J&J's hip and knee unit at up to $22 billion, almost double its own market value. J&J shareholders would have owned 50.1% of the combined company. J&J is leaning toward spinning off the unit as DePuy Synthes, targeting mid-2027. Reuters reported the unit sought around $20 billion and drew private equity interest. Both companies declined to comment.

Yahoo Finance
Oct 18th, 2026
Three undervalued UK stocks for October 2026: Morgan Sindall, Shell, Smith & Nephew

Simply Wall St has named three London-listed stocks it says trade below estimated fair value based on future cash flows: Morgan Sindall Group, Shell, and Smith & Nephew. The screen flags 23 more companies not covered. Morgan Sindall Group, a £1.8b construction and regeneration firm, saw its secured order book rise 39% to £12bn. Its Partnership Housing arm ties it to long-term contracts, though policy changes and planning delays pose risks. Shell has a market value of about £225.1b and revenue of $443.2b. Its LNG portfolio exceeds 60 million tons. Smith & Nephew, valued at £9.1b, relies on repeat implant procedures. New products drove 75% of first-half growth.

Yahoo Finance
Oct 6th, 2026
Smith+Nephew launches CARTIHEAL AGILI-C cartilage repair implant in Europe

Smith+Nephew has launched its CARTIHEAL AGILI-C Cartilage Repair Implant in Europe. The product, already introduced in the US during 2024, will be featured at the International Cartilage Regeneration & Joint Preservation Society Summit in Porto, Portugal from 8-10 October. The implant, composed of aragonite (a naturally occurring calcium carbonate), acts as a biphasic scaffold to repair cartilage, restore bone and relieve pain. A recent study published in the American Journal of Sports Medicine showed the implant resulted in higher overall Knee injury and Osteoarthritis Outcome Scores versus surgical standard of care for all time points out to 60 months. The implant will initially launch in twelve countries including Austria, Belgium, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Portugal, Spain, Switzerland and the UK.

Kalkine Media
Sep 10th, 2026
Smith+Nephew issues $700M 5.750% bonds due 2036 to refinance 2030 senior notes

Smith & Nephew has issued $700 million in senior notes with a 5.750% coupon maturing in 2036, netting $690.9 million after underwriting fees. The FTSE 100 medical technology firm will primarily use proceeds to fund a tender offer for its existing 2.032% senior notes due 2030, with remaining funds allocated to general corporate purposes. The refinancing replaces lower-yield debt with higher-coupon notes, reflecting current credit market conditions. BofA Securities, J.P. Morgan Securities, Mizuho Securities USA, and SMBC Nikko Securities America managed the transaction, which closed on 11 September 2026. Founded in Hull in 1856, Smith & Nephew operates across orthopaedics, sports medicine, ENT, and advanced wound management. The company employs approximately 17,000 people across 100 countries and reported annual sales of $6.2 billion in 2025.

Ticker Report
Sep 3rd, 2026
Corient Private Wealth LP Makes New $2 Million Investment in Smith & Nephew SNATS, Inc. $SNN

Corient Private Wealth LP purchased a new stake in Smith & Nephew SNATS, Inc. (NYSE:SNN – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 31,871 shares of the medical equipment provider’s stock, valued at approximately $1,999,000. Other large investors […]